A General Route to Anti-tumor Angucycline/Angucyclinones
A General Route to Anti-tumor Angucycline/Angucyclinones
批准号:
6949920
负责人:
DOUGLAS M MANS
金额:
$4.4万
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-09-01 至 2006-08-31
中文摘要
描述(由申请人提供):本提案中概述的研究目标是研究使用1,3-二卤-2-(三烷基硅基)苯作为1,3-苯并二苯胺前体作为苯并[a]蒽核心的一般途径的范围。利用一次性系绳将环加成物呈现在分子内,可以控制苯基环加成物的区域化学。所制得的苯并[a]蒽芯将进一步发展为天然产物rubiginone B1、urdamycinone B和IB-00208,它们是安环素/安环素家族天然产物中有效的抗肿瘤化合物。该反应将被研究,并将扩大1,3-苯并苯胺环加成的范围,使用正交法产生必要的苯中间体。这将允许一个受控的生成和反应的苯,以产生适当功能化的苯[a]蒽核心。利用所提出的3-苯并二炔方法,通过灵活的路线进行高效的化学合成,将为合成大量结构相似的安古霉素/安古霉素天然产物提供一种通用的合成策略,这些天然产物已被确定为癌症、抗菌、抗病毒和酶抑制剂治疗领域的潜在药物。
英文摘要
DESCRIPTION (provided by applicant): The goal of the research outlined in this proposal is to investigate the scope of using 1,3-dihalo-2- (trialkylsilyl) benzenes as 1,3-benzadiyne precursors as a general route to the benz[a]anthracene core. Using disposable tethers to render the cycloadditions intramolecular will control the regiochemistry of the benzyne cycloadditions. The benz[a]anthracene cores produced will be further elaborated into the natural products rubiginone B1, urdamycinone B, and IB-00208, which are potent antitumor compounds from the angucycline/angucyclinone family of natural products. The reaction will be investigated and will expand the scope of 1,3-benzadiyne cycloadditions by using orthogonal methods of generating the requisite benzyne intermediates. This will allow for a controlled generation and reaction of benzyne to produce appropriately functionalized benz[a]anthracene cores. Efficient chemical syntheses by flexible routes using the proposed, 3-benzadiyne methodology will provide a general synthetic strategy for the synthesis of a multitude of structurally similar angucycline/angucyclinone natural products, which have been identified as potential pharmaceuticals in the therapeutic areas of cancer, anti-bacterials, anti-virals, and enzyme inhibitors.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A General Route to Anti-tumor Angucycline/Angucyclinones
-
批准号:6832589
-
项目类别:
-
资助金额:$4.11万
-
财政年份:2004
-
负责人:DOUGLAS M MANS
-
依托单位:
海外基金